These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 9802936
1. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease. Bakri Hassan A, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I. J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936 [Abstract] [Full Text] [Related]
2. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response. Lacki JK, Leszczynski P, Kelemen J, Müller W, Mackiewicz SH. J Med; 1997 Oct; 28(1-2):99-107. PubMed ID: 9249616 [Abstract] [Full Text] [Related]
3. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K. J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [Abstract] [Full Text] [Related]
4. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels. Hajas A, Szodoray P, Barath S, Sipka S, Rezes S, Zeher M, Sziklai I, Szegedi G, Bodolay E. J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145 [Abstract] [Full Text] [Related]
5. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease. Bodolay E, Aleksza M, Antal-Szalmás P, Végh J, Szodoray P, Soltész P, Szegedi A, Szekanecz Z. J Rheumatol; 2002 Oct; 29(10):2136-42. PubMed ID: 12375323 [Abstract] [Full Text] [Related]
6. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. Neidhart M. J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986 [Abstract] [Full Text] [Related]
7. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity. Robak E, Sysa-Jedrzejewska A, Dziankowska B, Torzecka D, Chojnowski K, Robak T. Arch Immunol Ther Exp (Warsz); 1998 Mar; 46(6):375-80. PubMed ID: 9883317 [Abstract] [Full Text] [Related]
8. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA. J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987 [Abstract] [Full Text] [Related]
9. Serum cytokines in different histological variants of rheumatoid arthritis. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J. J Rheumatol; 2001 Jun; 28(6):1211-7. PubMed ID: 11409111 [Abstract] [Full Text] [Related]
10. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Chen DY, Hsieh TY, Chen YM, Hsieh CW, Lan JL, Lin FJ. Gerontology; 2009 Jun; 55(3):250-8. PubMed ID: 18849599 [Abstract] [Full Text] [Related]
11. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. Omdal R, Mellgren SI, Koldingsnes W, Jacobsen EA, Husby G. J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560 [Abstract] [Full Text] [Related]
12. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects. Arora V, Verma J, Marwah V, Kumar A, Anand D, Das N. Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832 [Abstract] [Full Text] [Related]
13. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. López P, Gómez J, Prado C, Gutiérrez C, Suárez A. J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405 [Abstract] [Full Text] [Related]
14. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY. J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792 [Abstract] [Full Text] [Related]
15. Mirthful laughter differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis. Matsuzaki T, Nakajima A, Ishigami S, Tanno M, Yoshino S. Rheumatology (Oxford); 2006 Feb; 45(2):182-6. PubMed ID: 16319105 [Abstract] [Full Text] [Related]
16. Studies of serum C-reactive protein in systemic lupus erythematosus. Williams RC, Harmon ME, Burlingame R, Du Clos TW. J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436 [Abstract] [Full Text] [Related]
17. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH. Ital J Biochem; 2005 Mar; 54(3-4):248-57. PubMed ID: 16688934 [Abstract] [Full Text] [Related]
18. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P, Langnickel D, Riemekasten G. Scand J Rheumatol; 2006 Mar; 35(3):209-16. PubMed ID: 16766368 [Abstract] [Full Text] [Related]
19. Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity. D'Auria L, Mussi A, Bonifati C, Mastroianni A, Giacalone B, Ameglio F. J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):11-5. PubMed ID: 10188143 [Abstract] [Full Text] [Related]
20. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC. Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]